Real-world experience of catheter ablation for atrial fibrillation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to gather real-world clinical data on the use of radiofrequency catheter ablation technologies for treating Paroxysmal and Persistent Atrial Fibrillation. It is an observational, prospective, multi-center registry that will assess clinical outcomes such as procedural efficiency, safety, and long-term effectiveness of the ablation procedures. Patient evaluations will occur at multiple time points, including pre-ablation, during the procedure, and at follow-up intervals of 10-12 weeks, 6 months, and 1 year post-ablation. The registry will also include assessments of complications and arrhythmia recurrence.

Why it matters

Who can join: the full rules

REAL AF Cohort

Inclusion Criteria:

* Symptomatic PAF (AF episode terminate spontaneously within 7 days) or PsAF (AF sustained beyond 7 days, but less than 365 days) subjects who, in the opinion of the investigator, are candidates for catheter ablation.
* \>18 years of age.
* Will be treated with Biosense Webster Inc. ablation technologies
* All AF ablations performed with BWI catheters are included. This includes repeat ablations where the index procedure was performed with a non-BWI catheter.
* Able and willing to participate in baseline and follow up evaluations
* Willing and able to provide informed consent, if applicable.

Exclusion Criteria:

* Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
* Long-standing persistent AF (AF greater than one year)
* In the opinion of the investigator, any known contraindication to an ablation procedure

CORE VA Cohort

Inclusion Criteria:

* Documented ventricular arrhythmia appropriate for catheter ablation.
* \>18 years of age.
* Will be treated with Biosense Webster Inc. ablation technologies
* Able and willing to participate in baseline and follow up evaluations
* Willing and able to provide informed consent, if applicable.

Exclusion Criteria:

* Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan.
* In the opinion of the investigator, any known contraindication to an ablation procedure.

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting
• Grandview Medical Center
  Birmingham, Alabama, United States Recruiting
• Cardiology Associates of Mobile
  Mobile, Alabama, United States Recruiting
• Valley Heart Rhythm Specialists
  Chandler, Arizona, United States Recruiting
• Pima Heart and Vascular
  Tucson, Arizona, United States Recruiting
• Arrhythmia Research Group
  Jonesboro, Arkansas, United States Recruiting

+25 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: April Bond, MS
• Email: abond@hrcrs.com
• Phone: 1-901-828-5707

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pulsed field ablation for atrial fibrillation in underrepresented minority patients

  This registry will test how well Boston Scientific pulsed field ablation works and how safe it is for Black, Hispanic, Asian, and other underrepresented adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 2 sites Icahn School of Medicine at Mount Sinai · New York, New York and 1 other locations · NCT07535268

• FARAPULSE pulsed-field waveform treatment for paroxysmal and persistent atrial fibrillation

  This will test new pulsed electrical waveforms delivered by the FARAPULSE PFA system to treat adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 3 sites Boston Scientific Corporation · Split and 3 other locations · NCT07444320

• Arrhythmia mapping with a paddle-shaped multi-electrode catheter

  This test uses a new high-density multi-electrode catheter to see if it can safely map atrial and ventricular arrhythmias in adults having catheter mapping and ablation.

  Recruiting at 5 sites Biosense Webster, Inc. · Bruges and 4 other locations · NCT07116525

• Conscious Sedation vs General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation

  This trial tests whether local anesthesia with conscious sedation can match general anesthesia for pulsed field ablation in adults with paroxysmal atrial fibrillation.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07877519

• Perioperative risks in adults with Brugada syndrome during anesthesia and related procedures

  This registry follows adults with Brugada syndrome to see how often dangerous heart rhythms occur around anesthesia and up to 30 days after.

  Recruiting Hospital Clinic of Barcelona · Barcelona, Barcelona · NCT07655102

• FARAFLEX Mapping and Pulsed Field Ablation for Atrial Fibrillation

  This trial tests the FARAFLEX Mapping and PFA System to see if it can safely help adults with drug-refractory paroxysmal or persistent atrial fibrillation.

  Recruiting at 13 sites Boston Scientific Corporation · Jonesboro, Arkansas and 12 other locations · NCT07575269

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.